Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03353753
Title Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus)
Acronym INVICTUS
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | NLD | ITA | GBR | FRA | FIN | ESP | DEU | CAN | BEL | AUS


No variant requirements are available.